These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 183799)

  • 61. Differing interactions between hexamethonium and tubocurarine, pancuronium or alcuronium at the neuromuscular junction.
    Pollard BJ; van der Spek AF
    Br J Anaesth; 1988 Oct; 61(4):419-24. PubMed ID: 2903757
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Analysis of blocking action of dimethyl dl-curine dimethochloride on neuromuscular transmission (author's transl)].
    Yang QZ; Lin LR; Tang XC
    Zhongguo Yao Li Xue Bao; 1982 Jun; 3(2):87-90. PubMed ID: 6287804
    [No Abstract]   [Full Text] [Related]  

  • 63. Effect of procyclidine on neuromuscular transmission.
    Salako LA
    Arch Int Pharmacodyn Ther; 1970 Apr; 184(2):233-9. PubMed ID: 4318995
    [No Abstract]   [Full Text] [Related]  

  • 64. [Influence of imipramine on curarism. II].
    Bertolini A; Greggia A; Patrignani A; Zappata A
    Boll Soc Ital Biol Sper; 1967 Jul; 43(13):800-1. PubMed ID: 4293402
    [No Abstract]   [Full Text] [Related]  

  • 65. Inhibition of mobilization of acetylcholine: the weak link in neuromuscular transmission during partial neuromuscular block with d-tubocurarine.
    Foldes FF; Chaudhry IA; Kinjo M; Nagashima H
    Anesthesiology; 1989 Aug; 71(2):218-23. PubMed ID: 2547326
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cerebrospinal fluid levels of d-tubocurarine in man.
    Matteo RS; Pua EK; Khambatta HJ; Spector S
    Anesthesiology; 1977 Jun; 46(6):396-9. PubMed ID: 860842
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Role of histamine in the hypotensive action of d-tubocurarine in humans.
    Moss J; Rosow CE; Savarese JJ; Philbin DM; Kniffen KJ
    Anesthesiology; 1981 Jul; 55(1):19-25. PubMed ID: 6166217
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Pharmacokinetics of d-tubocurarine in man: effect of an osmotic diuretic on urinary excretion.
    Matteo RS; Nishitateno K; Pua EK; Spector S
    Anesthesiology; 1980 Apr; 52(4):335-8. PubMed ID: 6767421
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Potency and duration of action of dimethyl tubocurarine.
    Schuh FT
    Br J Anaesth; 1977 Jun; 49(6):637-8. PubMed ID: 194614
    [No Abstract]   [Full Text] [Related]  

  • 70. The pharmacokinetics of d-tubocurarine with surgery involving salvaged autologous blood.
    Shanks CA; Avram MJ; Ronai AK; Bowsher DJ
    Anesthesiology; 1985 Feb; 62(2):161-5. PubMed ID: 3970367
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Elevated plasma binding cannot account for the burn-related d-tubocurarine hyposensitivity.
    Leibel WS; Martyn JA; Szyfelbein SK; Miller KW
    Anesthesiology; 1981 May; 54(5):378-82. PubMed ID: 7224206
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Two- vs. three-compartment model for analysis of d-tubocurarine pharmacokinetics.
    Shanks CA; Ramzan MI; Triggs EJ
    Anesthesiology; 1980 Apr; 52(4):375-6. PubMed ID: 7362066
    [No Abstract]   [Full Text] [Related]  

  • 73. Clinical pharmacokinetics of the non-depolarising muscle relaxants.
    Ramzan MI; Somogyi AA; Walker JS; Shanks CA; Triggs EJ
    Clin Pharmacokinet; 1981; 6(1):25-60. PubMed ID: 7018787
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Model determination for use in automated control of drug dosages: application to d-tubocurarine.
    Bradlow HS; Sherlock BG; Thornington RE; Solomon ES
    Med Biol Eng Comput; 1983 Mar; 21(2):119-27. PubMed ID: 6887984
    [No Abstract]   [Full Text] [Related]  

  • 75. Kinetics of d-tubocurarine disposition and pharmacologic response in rats.
    Morino A; Kitamura K; Katayama K; Kakemi M; Koizumi T
    J Pharmacokinet Biopharm; 1983 Feb; 11(1):47-61. PubMed ID: 6875809
    [TBL] [Abstract][Full Text] [Related]  

  • 76. An analytical pharmacodynamic model for nondepolarizing neuromuscular blocking agents.
    d'Hollander A; Delcroix C
    J Pharmacokinet Biopharm; 1981 Feb; 9(1):27-40. PubMed ID: 6453216
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Lack of effects of d-tubocurarine and pancuronium on the slow action potential of the guinea pig papillary muscle.
    Arimura H; Ikemoto Y; Ito T; Yoshitake J
    Can Anaesth Soc J; 1985 Sep; 32(5):484-90. PubMed ID: 4041950
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Clinical pharmacokinetics of muscle relaxants.
    Wingard LB; Cook DR
    Clin Pharmacokinet; 1977; 2(5):330-43. PubMed ID: 913003
    [No Abstract]   [Full Text] [Related]  

  • 79. Pharmacodynamics of tubocurarine in humans.
    Wingard LB; Cook DR
    Br J Anaesth; 1976 Sep; 48(9):839-45. PubMed ID: 183799
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Letter: Serum dTc and neuromuscular blockade in man.
    Anesthesiology; 1975 May; 42(5):644-5. PubMed ID: 165757
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.